AQR Arbitrage’s Ibere Pharmaceuticals IBER Stock Holding History

AQR Arbitrage’s Portfolio IBER Stock Details IBER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-206,415	Closed	-$2.08M	–	1217
2022 Q4	$2.08M	Hold	206,415	–	–	0.05%	392
2022 Q3	$2.05M	Buy	206,415 +106,415	+106%	+$1.05M	0.05%	472
2022 Q2	$981K	Buy	+100,000	New	+$981K	0.02%	585
2021 Q4	–	Sell	-76,900	Closed	-$745K	–	1351
2021 Q3	$745K	Buy	76,900 +1,900	+3%	+$18.4K	0.02%	531
2021 Q2	$725K	Buy	+75,000	New	+$730K	0.02%	546

AQR Arbitrage's IBER Position: Q1 2023 in Review

AQR Arbitrage sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 206,415 shares — an estimated $2.08M sold.

AQR Arbitrage first reported a position in IBER in Q2 2021 and held it in 5 quarters. The position peaked at $2.08M in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

AQR Arbitrage reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
AQR Arbitrage sold 206,415 Ibere Pharmaceuticals shares in Q1 2023, an estimated $2.08M.
AQR Arbitrage first reported a position in Ibere Pharmaceuticals in Q2 2021 and held it in 5 quarters.
AQR Arbitrage's Ibere Pharmaceuticals position peaked at $2.08M in Q4 2022.
0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on AQR Arbitrage's 13F filing for Q1 2023, filed 15 May 2023.